AU Patent

AU2007338843B2 — Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof

Assigned to Teva Womens Health Inc · Expires 2013-05-09 · 13y expired

What this patent protects

The present invention is directed to non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising progestin and methods of making and using the dosage forms to treat conditions in females in need thereof.

USPTO Abstract

The present invention is directed to non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising progestin and methods of making and using the dosage forms to treat conditions in females in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2007338843B2
Jurisdiction
AU
Classification
—
Expires
2013-05-09
Drug substance claim
No
Drug product claim
No
Assignee
Teva Womens Health Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.